About 9,020,000 results
Open links in new tab
GSK Announces Positive Topline Data on Co-Administration of AREXVY …
GSK Announces Positive Topline Data on Co-Administration of AREXVY …
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
US FDA approves expanded age indication for GSK’s AREXVY, the …
US FDA approves GSK’s AREXVY, the world’s first respiratory …
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the …
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
US FDA approves GSK’s Arexvy, the world’s first respiratory …
GSK shares positive data for AREXVY, its respiratory syncytial virus ...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
- Some results have been removed